The US sleep apnea implants market is anticipated to grow considerably at a CAGR of 7.9% during the forecast period (2021-2027). The high prevalence of sleep apnea across the country is a key factor creating demand for its treatment; thereby driving its market growth. The increasing rate of Chronic Obstructive Pulmonary Disease (COPD) patients in the US is further aiding to the market demand. According to the American lung association, in 2018, 16.4 million people, or 6.6% of adults, reported a diagnosis of any type of COPD (chronic bronchitis, emphysema, or COPD) in the US. The breathing problems such as COPD reduce the supply of oxygen to the brain and other parts of the body, thus leading to sleep apnea disorder. The high awareness of adverse effect of sleep apnea on patient health has created huge scope for the market growth in the US.
The US sleep apnea implants market covers segments including type, indication type, and end-user. Based on type, the market is segmented into hypoglossal neurostimulation devices, phrenic nerve stimulator, and palatal implants. Hypoglossal neurostimulation devices segment held major market share in 2020 based on type. The higher adoption of hypoglossal neurostimulation devices owing to better results compared to other devices is a key factor contributing to the high share of this market segment. Based on indication type, the market is segmented into obstructive sleep apnea and central sleep apnea. Based on end-user, the market is segmented into hospitals & clinics and homecare.
Some of the key players operating in the US sleep apnea market are 3B Medical, Inc., Circadiance LLC., ResMed Inc., Somnetics International, Inc., and Medtronic Plc. In order to sustain in the competitive market, these players adopt various strategies such as merger & acquisition, partnership & collaboration, expansions, joint ventures, and product development.
Research Methodology
The market study of the US sleep apnea implants market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the US Sleep Apnea Implants Industry
• Recovery Scenario of US Sleep Apnea Implants Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on Key Players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. US Sleep Apnea Implants Market, By Type
5.1.1. Hypoglossal Neurostimulation Devices
5.1.2. Phrenic Nerve Stimulator
5.1.3. Palatal Implants
5.2. US Sleep Apnea Implants Market, By Indication Type
5.2.1. Obstructive Sleep Apnea
5.2.2. Central Sleep Apnea
5.3. US Sleep Apnea Implants Market, By End-User
5.3.1. Hospitals & Clinics
5.3.2. Home Care
6. Company Profiles
6.1. 3B Medical, Inc.
6.2. Aeroflow, Inc.
6.3. AG Industries Ltd.
6.4. Apex Medical Corp.
6.5. Circadiance LLC
6.6. Curative Medical Inc.
6.7. Invacare Corp.
6.8. Koninklijke Philips N.V.
6.9. Medtronic PLC
6.10. ResMed Inc.
6.11. SleepNet Corp.
6.12. Somnetics International, Inc.
6.13. Somnarus Inc.
6.14. Whole You, Inc.
1. US SLEEP APNEA IMPLANTS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027($ MILLION)
2. US SLEEP APNEA IMPLANTS MARKET RESEARCH AND ANALYSIS BY INDICATION TYPE, 2020-2027($ MILLION)
3. US SLEEP APNEA IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)
1. IMPACT OF COVID-19 ON US SLEEP APNEA IMPLANTS MARKET, 2020-2027 ($ MILLION)
2. IMPACT OF COVID-19 ON US SLEEP APNEA IMPLANTS MARKET BY SEGMENT, 2020-2027 ($ MILLION)
3. RECOVERY OF US SLEEP APNEA IMPLANTS MARKET, 2021-2027(%)
4. US SLEEP APNEA IMPLANTS MARKET SHARE BY TYPE, 2020 VS 2027(%)
5. US SLEEP APNEA IMPLANTS MARKET SHARE BY INDICATION TYPE, 2020 VS 2027(%)
6. US SLEEP APNEA IMPLANTS MARKET SHARE BY END-USER, 2020 VS 2027(%)
7. US SLEEP APNEA IMPLANTS MARKET SIZE, 2020-2027($ MILLION)